GlassScriptPhysician profile
David L Galbut
NPI 1679570683
$1,706.49
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $22.16 · 2021: $188 · 2022: $228 · 2023: $259 · 2024: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $433.73 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $256.08 | 2023-2024 | Sternalock Blu System, Sternalock 360 System |
| Abbott Laboratories | $220.14 | 2024 | Epic |
| Intuitive Surgical, INC. | $194.47 | 2021-2022 | |
| Provisio Medical, INC. | $166.25 | 2022 | |
| Lexington Medical, INC. | $97.38 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Angiodynamics, INC. | $95.84 | 2019 | |
| Impulse Dynamics (USA) INC. | $52.00 | 2024 | Optimizer |
| Lsi Solutions INC | $43.81 | 2019-2023 | Cor Knot |
| Merck Sharp & Dohme LLC | $37.24 | 2023-2024 | Keytruda |
| Kerecis Limited | $28.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $22.16 | 2020 | |
| Medtronic, INC. | $16.67 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.57 | 2021 | |
| Urgo Medical North America, LLC | $14.15 | 2024 | Urgoclean Ag |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$700,796.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Galbut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.